Strategy


Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/maverick-therapeutics-and-takeda-announce-five-year-collaboration-to-advance-t-cell-engagement-therapies/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26
share

Nerlynx is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage human...

share

Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited announced that they have entered...